Afya Limited SEC filings document the company as a foreign private issuer reporting on Form 6-K and presenting financial information in Brazilian reais under IFRS. The filings include unaudited interim and annual consolidated financial statements, operating-result releases and balance-sheet disclosures covering cash, receivables, property and equipment, right-of-use assets, intangible assets, loans and financing, lease liabilities and accounts payable to selling shareholders.
The filing record also documents Afya’s capital-allocation actions, including dividend approvals and share repurchase disclosures, as well as medical-seat authorizations for Brazilian campuses and board-governance changes. These reports connect Afya’s education and medical practice solutions business with formal disclosures on capital structure, liquidity, campus approvals, ownership-related obligations and governance matters.
Afya Ltd Chief Financial Officer Luis Andre Carpintero Blanco reported routine equity compensation activity involving restricted stock units and related tax withholding. On May 7, 2026, he exercised derivatives to acquire 23,500 Class A common shares at a conversion price of zero, reflecting RSUs converting into shares on a one-for-one basis. To cover tax obligations, 6,463 Class A common shares were disposed of at $14.41 per share through a tax-withholding mechanism rather than an open-market sale. Following these transactions, he directly owned 68,140 Class A common shares. Footnotes explain that certain RSUs have no expiration date and either fully vested on May 5, 2026 or vest in tranches in May 2027, 2028 and 2029, contingent on continued service.
Afya Ltd vice president Junior Lelio de Souza reported routine equity compensation activity involving restricted stock units (RSUs). On May 7, 2026, he acquired 16,200 Class A common shares through RSU conversion and delivered 4,455 shares at $14.41 per share to cover tax obligations, a non‑market tax-withholding disposition rather than an open-market sale.
After these transactions, he directly owned 77,745 Class A common shares. The RSUs convert into common shares on a one-for-one basis. Footnotes show 14,200 RSUs vested on May 5, 2026 and 2,000 RSUs also vested, with an additional 18,000 RSUs scheduled to vest in tranches through May 2029, subject to continued service.
Afya Ltd Vice President Gustavo De Souza Portes Meirelles exercised equity awards and settled related taxes in shares. He converted 7,000 restricted stock units into Class A common shares, with 1,925 shares withheld as a tax-withholding disposition at $14.41 per share. After these transactions, he directly holds 7,612 Class A common shares and 24,500 restricted stock units. The RSUs convert into common shares on a one-for-one basis and vested as to 7,000 shares on May 5, 2026; the remaining RSUs vest in tranches of 10,500 shares on May 1, 2027 and 14,000 shares on May 1, 2028, subject to continued service.
Afya Ltd Vice President Erico Coelho Ribeiro exercised 10,200 restricted stock units into Class A common shares on May 7, 2026, then had 2,805 of those shares withheld at $14.41 per share to cover taxes. He now directly holds 32,725 Class A Common Shares. Footnotes state these RSUs convert one-for-one, vested as to 10,200 shares on May 5, 2026, with remaining RSUs scheduled to vest on May 1, 2027, subject to continued service.
Afya Ltd controller Welder Ferreira Santos reported routine equity compensation activity. On May 7, 2026, he exercised derivative awards for 5,739 Class A common shares and had 1,578 shares withheld in a tax-related disposition at $14.41 per share.
Following these transactions, he directly owned 39,161 Class A common shares. Footnotes explain that restricted stock units convert into common shares one-for-one, with 500 RSUs vesting on May 5, 2026 and additional RSUs scheduled to vest in 2027, 2028 and 2029, subject to continued service.
Afya Ltd executive Anibal Jose Grifo de Sousa reported equity compensation activity in the form of restricted stock units converting into Class A common shares. On May 7, 2026, he acquired 17,500 Class A shares through derivative exercises, while 4,813 shares were withheld to cover tax obligations at $14.41 per share. After the tax-withholding disposition, his direct holdings in Class A common shares were 62,687 shares.
The filing shows RSUs convert into common shares on a one-for-one basis. One RSU grant vested as to 1,500 shares on May 5, 2026, with the remaining RSUs scheduled to vest as to 3,000, 4,500 and 6,000 shares on the first day of May in 2027, 2028 and 2029, subject to his continued service. A separate RSU award fully vested on May 5, 2026, contributing to the exercised amounts.
Afya Limited delivered solid results for the three-month period ended March 31, 2026, with revenue of R$1,012,712 thousand, up from R$936,360 thousand a year earlier. Growth was driven mainly by higher tuition fees across its undergraduate and continuing education operations.
Operating income reached R$393,600 thousand and net income was R$261,763 thousand, compared with R$257,036 thousand in the prior-year period. Basic earnings per share rose to R$2.88, while diluted earnings per share were R$2.85.
Afya generated strong net cash from operating activities of R$466,796 thousand and ended the period with cash and cash equivalents of R$1,332,866 thousand. The company continued to return capital, approving dividends of R$307,377 thousand and repurchasing treasury shares for R$69,511 thousand, while maintaining loans and financing of R$2,124,512 thousand.
Afya Limited delivered steady growth in the first quarter of 2026, with revenue reaching R$1,012.7 million, up 8.2% from a year earlier, driven mainly by higher medical course prices, more non-medical undergrad students, the FUNIC acquisition and expansion in Continuing Education.
Adjusted EBITDA rose 4.0% to R$511.4 million, while the margin slipped to 50.5% from 52.5% as Afya increased spending in Continuing Education and Medical Practice Solutions to support its investment cycle. Net income grew 1.8% to R$261.8 million, and basic EPS improved to R$2.88.
Cash and cash equivalents climbed to R$1,332.9 million, and net debt excluding IFRS 16 fell to R$1,151.3 million, aided by strong operating cash flow and despite acquisitions, dividends and share repurchases. Afya reaffirmed its 2026 guidance, including revenue between R$3.95–4.10 billion and Adjusted EBITDA of R$1.7–1.8 billion, and highlighted a R$307.4 million dividend and ongoing buybacks.
Afya Ltd executive Anibal Jose Grifo de Sousa, V.P. Legal, Compliance & Government Relations, exercised stock options covering 19,000 Class A common shares at $11.83 per share. This option exercise converted derivative holdings into common stock and did not involve any open-market sale.
Following the transaction, he directly owns 50,000 Class A common shares. The related stock option for 19,000 shares, originally exercisable beginning on May 1, 2025 and expiring on May 1, 2028, now shows zero derivative shares remaining in this award.
Afya Ltd Vice President Junior Lelio de Souza exercised stock options to acquire 66,000 Class A common shares on April 22, 2026. The options had an exercise price of $11.83 per share. After these transactions, he directly holds 66,000 Class A common shares and 6,000 stock options.